AFAM Capital’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-111,193
Closed -$7.27M 165
2015
Q1
$7.27M Sell
111,193
-813
-0.7% -$54.1K 0.94% 32
2014
Q4
$7.28M Buy
112,006
+118
+0.1% +$7.6K 0.93% 32
2014
Q3
$6.73M Buy
111,888
+989
+0.9% +$64.6K 0.85% 37
2014
Q2
$7.68M Buy
110,899
+1,250
+1% +$81K 0.96% 28
2014
Q1
$7.17M Sell
109,649
-503
-0.5% -$32.7K 0.96% 28
2013
Q4
$6.82M Buy
110,152
+3,468
+3% +$201K 0.92% 33
2013
Q3
$5.72M Buy
106,684
+298
+0.3% +$15.3K 0.79% 45
2013
Q2
$4.85M Buy
+106,386
New +$4.61M 0.67% 62

Other funds holding STJ

AFAM Capital's STJ Position: Q2 2015 in Review

AFAM Capital sold out of St Jude Medical (STJ) in Q2 2015, closing a stake of 111,193 shares — an estimated $7.27M sold.

AFAM Capital first reported a position in STJ in Q2 2013 and held it in 8 quarters. The position peaked at $7.68M in Q2 2014. 608 funds tracked by Wall St. Rank hold STJ as of Q2 2015.

  • AFAM Capital reported no remaining St Jude Medical position as of Q2 2015 after selling out during the quarter.
  • AFAM Capital sold 111,193 St Jude Medical shares in Q2 2015, an estimated $7.27M.
  • AFAM Capital first reported a position in St Jude Medical in Q2 2013 and held it in 8 quarters.
  • AFAM Capital's St Jude Medical position peaked at $7.68M in Q2 2014.
  • 608 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2015.

Based on AFAM Capital's 13F filing for Q2 2015, filed 10 Aug 2015.